BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19410106)

  • 1. A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients.
    Jacq F; Foulldrin G; Savouré A; Anselme F; Baguelin-Pinaud A; Cribier A; Thibaut F
    Gen Hosp Psychiatry; 2009; 31(3):266-73. PubMed ID: 19410106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a web-based healthcare innovation to advance the quality of life and care of patients with an implantable cardioverter defibrillator (ACQUIRE-ICD): a randomized controlled trial.
    Skov O; Johansen JB; Nielsen JC; Larroudé CE; Riahi S; Melchior TM; Vinther M; Skovbakke SJ; Rottmann N; Wiil UK; Brandt CJ; Smolderen KG; Spertus JA; Pedersen SS
    Europace; 2023 Dec; 25(12):. PubMed ID: 38055845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Predictive of Quality of Life among Breast Cancer Patients.
    Daldoul A; Khechine W; Bhiri H; Ammar N; Bouriga R; Krir MW; Soltani S; Zoukar O; Rhim MS; Bouslah S; Dimassi S; Abbess I; Saidani Z; Zaied S
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1671-1675. PubMed ID: 29938464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients.
    Thylén I; Dekker RL; Jaarsma T; Strömberg A; Moser DK
    J Psychosom Res; 2014 Aug; 77(2):122-7. PubMed ID: 25077853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric disorders and quality of life in patients with implantable cardioverter defibrillators: a systematic review.
    de Ornelas Maia AC; Soares-Filho G; Pereira V; Nardi AE; Silva AC
    Prim Care Companion CNS Disord; 2013; 15(2):. PubMed ID: 23930235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quality of life in implantable cardioverter defibrillator patients.
    Suwanpasak A; Boonyapisit W
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S108-14. PubMed ID: 24772587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression, psychological distress, and quality of life in patients with cardioverter defibrillator with or without cardiac resynchronization therapy.
    Knackstedt C; Arndt M; Mischke K; Marx N; Nieman F; Kunert HJ; Schauerte P; Norra C
    Heart Vessels; 2014 May; 29(3):364-74. PubMed ID: 23732755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiences of adults living with an implantable cardioverter defibrillator for cardiovascular disease: a systematic review of qualitative evidence.
    Pike A; Dobbin-Williams K; Swab M
    JBI Evid Synth; 2020 Nov; 18(11):2231-2301. PubMed ID: 32813405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Hosting" an implantable cardioverter defibrillator: A phenomenological inquiry.
    Garrino L; Borraccino A; Peraudo E; Bobbio M; Dimonte V
    Res Nurs Health; 2018 Feb; 41(1):57-68. PubMed ID: 29171061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Screen-ICD trial. Screening for anxiety and cognitive therapy intervention for patients with implanted cardioverter defibrillator (ICD): a randomised controlled trial protocol.
    Berg SK; Herning M; Svendsen JH; Christensen AV; Thygesen LC
    BMJ Open; 2016 Oct; 6(10):e013186. PubMed ID: 27798030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of patient and partner quality of life and health outcomes in the first year after an implantable cardioverter defibrillator (ICD).
    Dougherty CM; Fairbanks AM; Eaton LH; Morrison ML; Kim MS; Thompson EA
    J Behav Med; 2016 Feb; 39(1):94-106. PubMed ID: 26345262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concerns about implantable cardioverter-defibrillator shocks mediate the relationship between actual shocks and psychological distress.
    Thylén I; Moser DK; Strömberg A; Dekker RA; Chung ML
    Europace; 2016 Jun; 18(6):828-35. PubMed ID: 26324839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary management of ventricular arrhythmias in heart failure.
    Kariki O; Georgopoulos M; Katsillis N; Chatziantoniou A; Koskina S; Zygouri A; Saplaouras A; Bazoukis G; Gkouziouta A; Vlachos K; Dragasis S; Mililis P; Adamopoulos S; Efremidis M; Letsas KP
    Am J Cardiovasc Dis; 2023; 13(4):207-221. PubMed ID: 37736352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing PTSD in Implantable Cardioverter Defibrillator Patients: State-of-the-Art Management of ICD Shock and PTSD.
    F SS; R H; A S; E J; S A; Z H; R N
    Curr Cardiol Rep; 2023 Sep; 25(9):1029-1039. PubMed ID: 37486571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity of Brugada syndrome disease manifestation and risk of new-onset depression or anxiety: a Danish nationwide study.
    Jespersen CHB; Krøll J; Bhardwaj P; Winkel BG; Jacobsen PK; Jøns C; Haarbo J; Kristensen J; Johansen JB; Philbert BT; Riahi S; Torp-Pedersen C; Køber L; Tfelt-Hansen J; Weeke PE
    Europace; 2023 May; 25(5):. PubMed ID: 37129985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Percutaneous Mitral Valve Repair Using the MitraClip
    Geis NA; Göbbel A; Kreusser MM; Täger T; Katus HA; Frey N; Schlegel P; Raake PW
    Life (Basel); 2022 Feb; 12(3):. PubMed ID: 35330095
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Etchegary H; Pullman D; Connors SP; Simmonds C; Young TL; Hodgkinson KA
    JRSM Cardiovasc Dis; 2017; 6():2048004017698614. PubMed ID: 35186284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillators.
    Singh SM; Murray B; Tichnell C; McClellan R; James CA; Barth AS
    Heart Rhythm O2; 2021 Aug; 2(4):388-393. PubMed ID: 34430944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Influence of Antiarrhythmic Device Intervention on Biopsychosocial Functioning and Anxiety in Patients with an Implanted Cardioverter Defibrillator.
    Karczewska O; Młynarska A
    Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33513691
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychosocial Stress Hastens Disease Progression and Sudden Death in Mice with Arrhythmogenic Cardiomyopathy.
    Agrimi J; Scalco A; Agafonova J; Williams Iii L; Pansari N; Keceli G; Jun S; Wang N; Mastorci F; Tichnell C; Murray B; James CA; Calkins H; Zaglia T; Paolocci N; Chelko SP
    J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33255451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.